Skip to main content
Premium Trial:

Request an Annual Quote

Trovagene Signs Deals to Distribute Liquid Biopsy Tests in Europe, Middle East

NEW YORK (GenomeWeb) – Trovagene said today that it has signed new distribution agreements for its Trovera liquid biopsy tests with seven companies across Europe and the Middle East.

These new strategic partners include Alliance Global for the Middle East, Africa, and Central and South Asia; Instituto Diagnostico and Sorgente Genetica Varelli in Italy; Progenetics in Israel; Amplitech in France, Belgium, and Switzerland; NM Genomix for Bulgaria and Eastern Europe; and Diagnostica Longwood in Spain and Portugal.

According to Trovagene, these partners will introduce the company's clinical tests to physicians, laboratories and cancer centers in their respective regional markets. They will also gain early access to the research-use only liquid biopsy kits and systems Trovagene is co-developing with Boreal Genomics.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.